Skip to main content

Immunoassay of Bromocriptine and Specificity of Antibody: Criteria for Choice of Antiserum and Marker Compound

  • Chapter
Drug Metabolite Isolation and Determination

Part of the book series: Methodological Surveys in Biochemistry and Analysis ((ANAY,volume 12))

Abstract

To develop an assay for bromocriptine (2-bromo- α-ergokryptine), different hapten compounds were used to produce various animal antisera. Since all these were predominantly specific to the tricyclic peptide moiety of bromocriptine, the affinity constant Kwas considered a sufficient criterion for selecting a high energy antibody. The K value for the favoured antiserum (#270979) was 0.9 x 10 9 1/M. With the favoured tracer ligand, a detection limit of 0.17 ng/ml was achieved for bromocriptine in equilibrium with its epimer bromocriptinine. Metabolites such as the 8′-hydroxy derivative show virtually no cross-reaction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weber, H.P. (1980) in Ergot Compounds and Brain Function [VoL 23, Adv. Biochem. Psychopharmacol] (Goldstein, M., Calne, D.B., Lieberman, A. & Thorner, M.O., eds.) , Raven Press, New York, pp. 25–34.

    Google Scholar 

  2. Flückiger, E. & Wagner, H.-R. (1968)Experientia24, 1130.

    Google Scholar 

  3. Hökfelt, T. & Fuxe, K. (1972) in Brain-Endocrine Interaction (Knigge, K.M., Scott, D.E. & Weindl, A., eds.) , Karger, Basel, pp. 181–223.

    Google Scholar 

  4. Calne, D.B., Teychenne, P.F., Claveria, LE., Eastman, R., Greenacre, J.K. & Petrie, A. (1974)Br. Med. J. 4, 442–444

    Article  CAS  Google Scholar 

  5. Yalow, R.S. & Berson, S.A. (1971) In Competitive Protein Binding Assays (Odell, W.D. & Daughaday, W.H., eds.) , Lippincott, Philadelphia, pp. 1–21.

    Google Scholar 

  6. Levy, A., Kawashima, K. & Spector, S. (1976)Life Sci. 19, 1421–1429.

    Article  CAS  Google Scholar 

  7. Rosenthaler, J. & Munzer, H. (1976)Experientia32, 234–235.

    Article  CAS  Google Scholar 

  8. Rosenthaler, J., Nimmerfall, F., Sigrist, R. & Munzer, H. (1977)Eur. J. Biochem. 80, 603–609.

    Article  CAS  Google Scholar 

  9. Rosenthaler, J., Pacha, W.L., Koeberle, S. & Beveridge, T. (1980) in Phenothiazines and Structurally Related Drugs: Basic and Clinical Studies (Usdin, E., Eckert, H. & Forrest, I.S., ) Elsevier/North Holland, New York, pp. 121–124

    Google Scholar 

  10. Eckert, H., Kiechel, J.R., Rosenthaler, J., Schmidt, R. & Schreier, E. (1978) in Ergot Alkaloids and Related Compounds, Vol. 49, Handbook of Experimental Pharmacology (Berde, B. & Schild, H.O., eds.) Springer-Verlag, Berlin, pp. 780–782.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this chapter

Cite this chapter

Rosenthaler, J., Munzer, H., Voges, R. (1983). Immunoassay of Bromocriptine and Specificity of Antibody: Criteria for Choice of Antiserum and Marker Compound. In: Reid, E., Leppard, J.P. (eds) Drug Metabolite Isolation and Determination. Methodological Surveys in Biochemistry and Analysis, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4484-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4484-1_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4486-5

  • Online ISBN: 978-1-4684-4484-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics